789 related articles for article (PubMed ID: 19392907)
61. The correlation between prolonged corrected QT interval with the frequency of respiratory arrest, endotracheal intubation, and mortality in acute methadone overdose.
Farsi D; Mirafzal A; Hassanian-Moghaddam H; Azizi Z; Jamshidnejad N; Zehtabchi S
Cardiovasc Toxicol; 2014 Dec; 14(4):358-67. PubMed ID: 24811951
[TBL] [Abstract][Full Text] [Related]
62. Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study.
Bukten A; Skurtveit S; Gossop M; Waal H; Stangeland P; Havnes I; Clausen T
Addiction; 2012 Feb; 107(2):393-9. PubMed ID: 21883606
[TBL] [Abstract][Full Text] [Related]
63. Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis.
Pappachan JM; Sebastian J; Bino BC; Jayaprakash K; Vijayakumar K; Sujathan P; Adinegara LA
Postgrad Med J; 2008 Apr; 84(990):205-10. PubMed ID: 18424578
[TBL] [Abstract][Full Text] [Related]
64. Maternal methadone therapy increases QTc interval in newborn infants.
Parikh R; Hussain T; Holder G; Bhoyar A; Ewer AK
Arch Dis Child Fetal Neonatal Ed; 2011 Mar; 96(2):F141-3. PubMed ID: 21081591
[TBL] [Abstract][Full Text] [Related]
65. Prolonged QT interval corrected for heart rate during diabetic ketoacidosis in children.
Kuppermann N; Park J; Glatter K; Marcin JP; Glaser NS
Arch Pediatr Adolesc Med; 2008 Jun; 162(6):544-9. PubMed ID: 18524745
[TBL] [Abstract][Full Text] [Related]
66. Tapering from Methadone or Buprenorphine during Pregnancy: Maternal and Neonatal Outcomes in Norway 1996-2009.
Welle-Strand GK; Skurtveit S; Tanum L; Waal H; Bakstad B; Bjarkø L; Ravndal E
Eur Addict Res; 2015; 21(5):253-61. PubMed ID: 25967268
[TBL] [Abstract][Full Text] [Related]
67. Methadone Therapy in Underserved Urban Community: QTc Prolongation and Life-Threatening Ventricular Arrhythmias.
Chowdhury M; Wong J; Cheng A; Khilkin M; Palma E
Cardiovasc Ther; 2015 Jun; 33(3):127-33. PubMed ID: 25825202
[TBL] [Abstract][Full Text] [Related]
68. Buprenorphine replacement therapy: a confirmed benefit.
Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
[TBL] [Abstract][Full Text] [Related]
69. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
[TBL] [Abstract][Full Text] [Related]
70. Substitution of (R,S)-methadone by (R)-methadone: Impact on QTc interval.
Ansermot N; Albayrak O; Schläpfer J; Crettol S; Croquette-Krokar M; Bourquin M; Déglon JJ; Faouzi M; Scherbaum N; Eap CB
Arch Intern Med; 2010 Mar; 170(6):529-36. PubMed ID: 20308640
[TBL] [Abstract][Full Text] [Related]
71. [Buprenorphine or methadone for detoxification of young opioid addicts?].
Ebner R; Schreiber W; Zierer C
Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
[TBL] [Abstract][Full Text] [Related]
72. Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth With Opioid Dependence.
Poole SA; Pecoraro A; Subramaniam G; Woody G; Vetter VL
J Addict Med; 2016; 10(1):26-33. PubMed ID: 26690291
[TBL] [Abstract][Full Text] [Related]
73. QT interval prolongation in opioid agonist treatment: analysis of continuous 12-lead electrocardiogram recordings.
Isbister GK; Brown AL; Gill A; Scott AJ; Calver L; Dunlop AJ
Br J Clin Pharmacol; 2017 Oct; 83(10):2274-2282. PubMed ID: 28488266
[TBL] [Abstract][Full Text] [Related]
74. Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention.
Burns L; Randall D; Hall WD; Law M; Butler T; Bell J; Degenhardt L
Addiction; 2009 Aug; 104(8):1363-72. PubMed ID: 19549053
[TBL] [Abstract][Full Text] [Related]
75. QTc values among children and adolescents presenting to the emergency department.
Van Dorn CS; Johnson JN; Taggart NW; Thorkelson L; Ackerman MJ
Pediatrics; 2011 Dec; 128(6):e1395-401. PubMed ID: 22123891
[TBL] [Abstract][Full Text] [Related]
76. QTc dispersion in haemodialysis patients with cardiac complications.
Nakamura S; Ogata C; Aihara N; Sasaki O; Yoshihara F; Nakahama H; Inenaga T; Kimura G; Kawano Y
Nephrology (Carlton); 2005 Apr; 10(2):113-8. PubMed ID: 15877668
[TBL] [Abstract][Full Text] [Related]
77. Hypogonadism in men receiving methadone and buprenorphine maintenance treatment.
Hallinan R; Byrne A; Agho K; McMahon CG; Tynan P; Attia J
Int J Androl; 2009 Apr; 32(2):131-9. PubMed ID: 17971165
[TBL] [Abstract][Full Text] [Related]
78. Prospective study of QTc changes among former opiate addicts since admission to methadone maintenance treatment: benzodiazepine risk.
Peles E; Linzy S; Kreek MJ; Adelson M
J Addict Med; 2013; 7(6):428-34. PubMed ID: 24145160
[TBL] [Abstract][Full Text] [Related]
79. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L
Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939
[TBL] [Abstract][Full Text] [Related]
80. Driving under the influence (DUI) among patients in opioid maintenance treatment (OMT): a registry-based national cohort study.
Bukten A; Herskedal A; Skurtveit S; Bramness JG; Clausen T
Addiction; 2013 Nov; 108(11):1954-61. PubMed ID: 23773400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
